Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

972
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
972
Viral Mutations00:36

Viral Mutations

39.6K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
39.6K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

931
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
931
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.2K
Vaccinations01:51

Vaccinations

51.3K
Overview
51.3K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

6.9K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Topical Imiquimod for Lentigo Maligna in a Nonagenarian.

Life (Basel, Switzerland)·2026
Same author

Sodium-glucose cotransporter-2 inhibitor therapy and penile lichen sclerosus: Clinical observations suggesting a role in disease development through urinary occlusion.

International journal of STD & AIDS·2026
Same author

Partial Efficacy of Low-Dose Naltrexone in Post-Orgasmic Illness Syndrome with Lichen Sclerosus: A Case Report.

Clinical and experimental dermatology·2026
Same author

Neisseria meningitidis carriage, antimicrobial resistance, and risk factors in UK men who have sex with men.

The Journal of infection·2026
Same author

Switching to doravirine-based antiretroviral therapy without genotypic resistance tests in virologically suppressed people with HIV.

AIDS (London, England)·2026
Same author

Penile Cancer-A Preventable Cause of Death in Elderly Men.

British journal of hospital medicine (London, England : 2005)·2026

Related Experiment Video

Updated: Jan 16, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.9K

Human papillomavirus: An update.

Manik Kohli1, Christopher Bunker2, Georgios Kravvas2

  • 1Department of Sexual Health and HIV, Central and North West London NHS Foundation Trust, London, United Kingdom; Institute for Global Health, University College London, London, United Kingdom.

Clinics in Dermatology
|September 26, 2025
PubMed
Summary
This summary is machine-generated.

Human papillomaviruses (HPV) are common global infections causing various lesions and cancers. While prophylactic vaccination is successful, research is exploring the potential of postexposure vaccination for broader HPV management.

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.1K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.1K

Related Experiment Videos

Last Updated: Jan 16, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

12.9K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.1K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.1K

Area of Science:

  • Virology
  • Oncology
  • Epidemiology

Background:

  • Human papillomaviruses (HPV) are a prevalent global viral infection with over 450 identified types.
  • HPV infections can lead to a range of conditions, from benign warts to premalignant lesions and anogenital cancers.
  • Despite recognized roles in disease pathogenesis, robust evidence for HPV screening and management strategies is often limited.

Purpose of the Study:

  • To review the current understanding of HPV-related diseases.
  • To assess the effectiveness of prophylactic HPV vaccination.
  • To explore the emerging interest in postexposure HPV vaccination strategies.

Main Methods:

  • Literature review of HPV epidemiology and pathogenesis.
  • Analysis of data on prophylactic HPV vaccination programs.
  • Examination of research trends concerning postexposure vaccination.

Main Results:

  • HPV infections are widespread, causing diverse clinical manifestations including warts, neoplasia, and cancers.
  • Prophylactic HPV vaccination has demonstrated success in high-income countries for specific populations.
  • There is increasing scientific and clinical interest in evaluating the efficacy of postexposure HPV vaccination.

Conclusions:

  • HPV poses a significant global health challenge due to its prevalence and associated diseases.
  • Prophylactic vaccination represents a successful public health intervention for HPV prevention.
  • Further research into postexposure vaccination is warranted to expand HPV management options.